Gilead-initiated or Gilead-supported Abstracts Published at CROI 2025

	F/TAF
Glidden, D	WEIGHT CHANGE ON F/TAF VS PLACEBO: USING COMMON F/TDF GROUPS TO BRIDGE DATA ACROSS CLINICAL TRIALS
Mujuru, HA	WEEK 24 OUTCOMES OF F/TAF PLUS COBICISTAT-BOOSTED PROTEASE INHIBITORS IN CHILDREN ≥2 Y AND ≥14 KG
	B/F/TAF
Avihingsanon, A	ALLIANCE OLE: SWITCH TO B/F/TAF IN PEOPLE WITH BOTH HIV-1 AND HBV
D’Antoni, M	HIV-1 RESISTANCE ANALYSIS OF TREATMENT-NAÏVE PEOPLE WITH HIV AND HBV RECEIVING B/F/TAF OR DTG+F/TDF
Post, F	RENAL OUTCOMES IN PEOPLE WITH HIV-1 AND RENAL IMPAIRMENT TREATED WITH B/F/TAF IN RANDOMIZED TRIALS
	TREATMENT PIPELINE
Ogbuagu, O	EFFICACY AND SAFETY OF LONG-ACTING LENACAPAVIR, TEROPAVIMAB, AND ZINLIRVIMAB: PHASE 2 PRIMARY OUTCOME WEEK 26
Imperial, M	PHARMACOKINETIC MODELING OF MISSED DOSE SCENARIO OF ORAL WEEKLY ISLATRAVIR PLUS LENACAPAVIR
Hansen, D	IN VITRO RESISTANCE PROFILE FOR GS-1720, A POTENT ONCE-WEEKLY ORAL INSTI IN CLINICAL DEVELOPMENT
VanderVeen, L	RESISTANCE ANALYSIS OF WEEKLY ISLATRAVIR PLUS LENACAPAVIR IN PEOPLE WITH HIV AT 48 WEEKS
Margot, N	BICTEGRAVIR + LENACAPAVIR: BASELINE AND WEEK 48 RESISTANCE IN ARTISTRY-1 PHASE 2
	HIV PREVENTION INCLUDING PIPELINE
Gill, K	LENACAPAVIR PHARMACOKINETICS, SAFETY, AND EFFICACY IN ADOLESCENTS AND ADULTS IN PURPOSE 1
Jogiraju, V	PHARMACOKINETICS AND SAFETY OF ONCE-YEARLY FORMULATIONS OF LENACAPAVIR
Kiweewa, FM	ADHERENCE TO F/TAF IN CISGENDER WOMEN PREVENTS HIV WITH LOW RISK OF RESISTANCE OR DIAGNOSTIC DELAY
Tao, L	THE INFLUENCE OF RACIALIZED ECONOMIC SEGREGATION ON UNMET HIV PREVENTION NEEDS IN THE REAL WORLD
Mansoor, LE	PURPOSE 1: PREFERENCE FOR TWICEYEARLY INJECTION VS DAILY ORAL PILLS FOR HIV PREP IN CISGENDER WOMEN
Montgomery, ET	QUALITATIVE ASSESSMENT OF ACCEPTABILITY AND PREFERENCES FOR INJECTABLE AND ORAL PREP IN PURPOSE 1
Tao, L	US SOCIOECONOMIC DISPARITIES AND GEOGRAPHIC VARIATIONS IN HIV PREEXPOSURE PROPHYLAXIS PROVIDERS
	HIV CURE
Dong, K	EVALUATION OF 2 BNABS PLUS VESATOLIMOD IN EARLY-TREATED SOUTH AFRICAN WOMEN WITH HIV-1 DURING ATI
Huang, S	T-CELL RESPONSES INDUCED BY GS-1966+GS-1144 VACCINES IN VIRALLY SUPPRESSED PEOPLE WITH HIV
	HIV TREATMENT (OTHER)
Mignano, J	DETECTION AND LINKAGE OF PLWH WHO ARE OUT OF CARE IN 94 EMERGENCY DEPARTMENTS ACROSS THE US
	COVID-19
Berry, M	PATTERNS OF REMDESIVIR INITIATION IN IMMUNOCOMPROMISED PATIENTS HOSPITALIZED WITH COVID-19
Ferreira, AM	MACHINE LEARNING IDENTIFIES PREDICTORS OF DELAYED OR NO REMDESIVIR USE IN HOSPITALIZED COVID-19 PATIENTS

Locally Supported Studies, Investigator-Sponsored Research and Collaborative Studies: CROI 2025

	B/F/TAF
Osuala, E	PHARMACOKINETICS OF TWICE-DAILY TAF IN ADULTS WITH HIV-ASSOCIATED TB ON BIC/FTC/TAF AND RIFAMPICIN
Loutfy, M	ESTRADIOL CONCENTRATIONS IN TRANS WOMEN ON B/F/TAF COMPARED TO THOSE WITHOUT HIV
Coppinger, C	PHARMACOKINETICS OF SWITCHING TO B/F/TAF IN PWH POST RENAL TRANSPLANT: BIC-SWITCH STUDY
Behrens, G	INTEGRASE INHIBITOR VERSUS PROTEASE INHIBITOR-BASED THERAPY FOR PATIENTS WITH ADVANCED HIV-DISEASE
Ombajo, L	SWITCH OF VIRALLY SUPPRESSED ADULTS ? 60 YEARS FROM FIRST-LINE ART TO B/F/TAF: WEEK 96 RESULTS
Diaz-Garcia, C	INFLAMMATORY SIGNATURES AMONG PEOPLE WITH HIV INITIATING DTG/3TC VS. B/F/TAF IN THE CORIS COHORT
Serrano-Villar, S	IMPACT OF SWITCHING FROM DTG/3TC TO B/F/TAF ON WEIGHT, CHOLESTEROL, AND INFLAMMATION IN HIV
	B/F/TAF
Ryan, P	SIMPLIFIED ACCESS AND RETENTION MODEL FOR VULNERABLE PEOPLE WITH HIV: SIMPLIFIED STUDY RESULTS
Peyrouny-Mazeau, A	PREDICTIVE FACTORS OF VIROLOGICAL FAILURE AFTER SWITCHING TO B/F/TAF (ANRS-CO3-AQUIHIV-NA)
Marc, J	HIGH PREVALENCE OF BASELINE NRTI RESISTANCE IN PWH SWITCHED FROM SECOND-LINE PI/R TO B/F/TAF
Bellecave, P	REAL-WORLD ROBUSTNESS OF B/F/TAF AT VIROLOGIC FAILURE IN THE ANRS-CO3- AQUIHIV-NA COHORT
Bourgi, K	RE-EXAMINING INSTI EFFECTS ON WEIGHT GAIN AMONG TREATMENT-NAÏVE PEOPLE WITH HIV IN NORTH AMERICA
Homeus, F	WEIGHT CHANGE IN TRIAL OF SWITCHING FROM SECOND-LINE bPI TO B/F/TAF IN A CONTEXT OF FOOD INSECURITY
	F/TAF
Bamford, A	GENOTYPIC RESISTANCE IN THE AFRICAN PAEDIATRIC CHAPAS-4 TRIAL OF SECOND-LINE ANTIRETROVIRAL THERAPY
	LENACAPVIR HIV TREATMENT
Mounzer, K	FIRST YEAR OF LENACAPAVIR LONG-ACTING INJECTABLE USE IN THE OPERA COHORT
	PREGNANCY
Wu, D	DEPRESSION, SLEEP, AND ANXIETY AMONG PREGNANT AND POSTPARTUM WOMEN USING DOLUTEGRAVIR AND EFAVIRENZ
	Acute HIV Infection
Paul, R	BRAIN VOLUME NORMALIZATION AFTER 96 WEEKS OF ART STARTED DURING ACUTE HIV INFECITON
Capoferri, A	EARLY HIV-1 GENETIC DIVERSITY INCLUDES CTL AND DRUG RESISTANCE MUTATIONS
Takata, H	RV550: IL-15 SUPERAGONIST N-803 WITH ART IN ACUTE HIV INFECTION ENHANCES T AND NK CELL PROLIFERATION
Sacdalan, C	RV550: SAFETY AND VIROLOGICAL OUTCOMES IN BLOOD AND LYMPH NODES OF N-803 WITH ART IN ACUTE INFECTION
Chan, P	NEURONAL INJURY IN A SUBSET OF PWH DURING ACUTE HIV INFECTION AND UP TO 5 YEARS AFTER IMMEDIATE ART
Chan, P	INCREASING METHAMPHETAMINE USE AND GROUP SEX OBSERVED IN MSM WITH ACUTE HIV INFECTION IN BANGKOK
	CVD & WEIGHT
Lu, M	PLAQUE, INFLAMMATION, SUBCLINICAL MYOCARDIAL INJURY AND MACE IN THE REPRIEVE MECHANISTIC SUBSTUDY
Erlandson, K	NO EVIDENCE OF A DETRIMENTAL EFFECT OF PITAVASTATIN ON NEUROCOGNITIVE FUNCTION AMONG PEOPLE WITH HIV
Bloomfield, G	HEART FAILURE RISK AND EVENTS IN PEOPLE WITH HIV IN THE REPRIEVE TRIAL
Kileel, E	RISK OF OBESITY, CARDIOMETABOLIC DISEASE AND MACE AFTER SWITCH TO AN INTEGRASE INHIBITOR IN REPRIEVE
Zhou, X	STATIN EFFECT HETEROGENEITY ON PLAQUE VOLUME & COMPOSITION IN THE REPRIEVE MECHANISTIC SUBSTUDY
Smith, E	TIME-UPDATED WIN RATIO ALIGNS WITH PRIMARY REPRIEVE FINDINGS AND SUGGESTS EARLY PITAVASTATIN BENEFIT
Mavarani, L	RISK FACTORS ASSOCIATED WITH EXTREME WEIGHT GAIN IN PEOPLE WITH HIV
	Liver Health
Liegeon, G	IMPACT OF A HCV TEST AND TREAT CAMPAIGN ON HEPATITIS C INCIDENCE IN THE ANRS PREVENIR PREP STUDY
Riebensahm, C	DETERMINANTS OF STEATOTIC LIVER DISEASE AMONG PEOPLE WITH HIV IN EUROPE AND AUSTRALIA
	Cancer
Han, W	CANCER INCIDENCE IN WOMEN WITH HIV: A COMBINED D:A:D AND RESPOND ANALYSIS
	COVID-19
Bolzenius, J	STRUCTURAL BRAIN VOLUMES DECREASE AFTER SARS-COV-2 INFECTION AMONG PEOPLE WITH HIV
Huang, L	LONG COVID IS A MULTISYSTEM DISORDER: ASSESSMENT OF THE NATIONAL ACADEMIES DEFINITION
Ocampo, F	COGNITIVE TRAJECTORIES 1 YEAR BEFORE AND AFTER COVID-19 IN AN EARLY TREATED HIV COHORT
Ocampo, F	IMMUNE & VIROLOGIC TRAJECTORIES 1.5 YEARS BEFORE AND AFTER COVID-19 IN AN EARLY-TREATED HIV COHORT
	Frailty
Erlandson, K	FRAILTY IS ASSOCIATED WITH HIGHER MACE INCIDENCE BUT DOES NOT APPEAR TO MODIFY PITAVASTATIN EFFECTS
Kulik, G	PROGNOSTIC FACTORS OF PHYSICAL FUNCTION DECLINE IN THE PREPARE STUDY
	HIV TREATMENT (OTHER)
Vo, P	UNTANGLING THE IMPACT OF CD101 ON HIV-1 TRANSMISSION
Magagnoli, J	IMPACT OF RESISTANCE TO ANTIRETROVIRAL THERAPY AMONG VETERANS WITH HUMAN IMMUNODEFICIENCY VIRUS
Garcia-Deltoro, M	DEVELOPMENT OF A HIV RISK PREDICTION MODEL USING ELECTRONIC HEALTH RECORD DATA IN SPAIN
	HIV CURE
Smith, G	SENSITIVITY OF HIV-1 CRF01_AE ENVELOPES TO BROADLY NEUTRALIZING ANTIBODIES VRC07-523LS AND PGDM1400LS
Takata, H	TARGETING TCF-1 TO POTENTIATE THE FUNCTIONAL CAPACITY OF HIV/SIV-SPECIFIC CD8+ T CELLS
Li, Y	MAXIMIZING BENEFITS TO PARTICIPANTS IN ANALYTIC TREATMENT INTERRUPTION WITH ANTIBODY INFUSIONS
	HIV PREVENTION
Hanscom, B	ESTIMATION OF PREVENTION-EFFECTIVE CAB-LA CONCENTRATIONS AMONG MSM/TGW IN HPTN 083
Delany- Moretlwe, S	PERFORMANCE OF HIV RNA SCREENING IN THE CONTEXT OF LONG-ACTING INJECTABLE CABOTEGRAVIR IN HPTN 084
Landovitz, R	RESPONSE TO HIV TREATMENT AFTER LONG-ACTING CABOTEGRAVIR PREEXPOSURE PROPHYLAXIS IN HPTN 083
Delany- Moretlwe, S	NO INCREASED RISK FOR HYPERTENSION WITH CAB-LA COMPARED TO TDF/FTC FOR PREP: RESULTS FROM HPTN 084
Bunting, S	HIV DIAGNOSIS FOLLOWING DISCHARGE FROM PSYCHIATRIC HOSPITALIZATION: A CLAIMS-BASED, REAL-WORLD STUDY
Fogel, J	USE OF DNA PROFILING TO RESOLVE DISCREPANT HIV TESTS IN THE SETTING OF INJECTABLE CABOTEGRAVIR PREP
Yin, Z	LEVERAGING COMMUNITY TO PROVIDE PREP TO KEY POPULATION IN CHINA: RESULTS FROM A PREP CLINICAL TRIAL
	HIV PREVENTION
Nuwagaba- Biribonwoha, H	HIGH INCIDENCE OF CURABLE SEXUALLY TRANSMITTED INFECTIONS IN HPTN 084: A TERTIARY ANALYSIS
Kabami, J	HIGH STI PREVALENCE AND LOW PAST PREP USE AMONG WOMEN WHO ENGAGE IN SEX WORK IN SOUTHWESTERN UGANDA
Li, C	DIGITAL STRATEGY TO IMPROVE PREP ADHERENCE AMONG MSM: A STEPPED-WEDGE RANDOMIZED TRIAL IN CHINA